<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-20794" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Dyskeratosis Congenita</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Garofola</surname>
            <given-names>Craig</given-names>
          </name>
          <aff>Lewis Gale Montgomery</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Nassereddin</surname>
            <given-names>Ali</given-names>
          </name>
          <aff>WakeMed Health and Hospitals</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Gross</surname>
            <given-names>Gary P.</given-names>
          </name>
          <aff>Lewis Gale Hospital Montgomery</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Craig Garofola declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Ali Nassereddin declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Gary Gross declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>26</day>
          <month>6</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-20794.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Dyskeratosis congenita, also known as Zinsser-Engman-Cole syndrome, is an uncommon genodermatosis classically associated with the triad of oral leukoplakia, nail dystrophy, and reticular hyperpigmentation. Most affected by the syndrome have a defect in the dyskeratosis congenita 1 (DKC1) gene which encodes the dyskerin protein involved in telomere maintenance. Inheritance is most commonly x-linked recessive, and subsequently, males are affected three times more frequently than females. Clinical findings vary widely and may include atrophic wrinkled skin, eye disease, and bone marrow failure. Treatment is difficult and largely depends on an interprofessional approach. This activity describes the pathophysiology, evaluation, and management of dyskeratosis congenita and highlights the role of the interprofessional team in the care of affected patients.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the pathophysiology of dyskeratosis congenita.</p></list-item><list-item><p>Review the presentation of dyskeratosis congenita.</p></list-item><list-item><p>Outline the treatment options for dyskeratosis congenita.</p></list-item><list-item><p>Explain the importance of improving coordination amongst the interprofessional team to enhance care for patients affected by dyskeratosis congenita.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=20794&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=20794">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-20794.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Dyskeratosis congenita (DKC), which is also known as Zinsser-Engman-Cole syndrome, is a genodermatosis originally&#x000a0;described by Zinsser in 1906.<xref ref-type="bibr" rid="article-20794.r1">[1]</xref> It is an uncommon syndrome classically associated with the triad of oral leukoplakia, nail dystrophy, and reticular hyperpigmentation.<xref ref-type="bibr" rid="article-20794.r2">[2]</xref> The majority of people affected by the syndrome have a defect in the&#x000a0;<italic toggle="yes">DKC1</italic>&#x000a0;gene encoding the dyskerin protein which is involved in telomere maintenance.<xref ref-type="bibr" rid="article-20794.r3">[3]</xref> Inheritance is most commonly x-linked recessive, and subsequently, males are three times more likely to be affected than females. Clinical findings vary widely and may include atrophic wrinkled skin, eye disease, and bone marrow failure. Treatment is difficult and largely requires an interprofessional approach.</p>
      </sec>
      <sec id="article-20794.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The defective preservation of telomeres causes dyskeratosis congenita.<xref ref-type="bibr" rid="article-20794.r3">[3]</xref> Telomeres are sequences of nucleotides at the ends of chromosomes that protect the chromosomes from progressively shortening after multiple rounds of DNA replication. The genes found to be defective in&#x000a0;DKC are all related to telomere preservation.<xref ref-type="bibr" rid="article-20794.r4">[4]</xref> The most common gene, <italic toggle="yes">DKC1</italic>, encodes for dyskerin protein and is inherited in an x-linked recessive fashion. Dyskerin is directly involved in stabilizing&#x000a0;an enzyme called telomerase that is responsible for catalyzing a reaction that&#x000a0;sustains the length of telomeres.<xref ref-type="bibr" rid="article-20794.r5">[5]</xref><xref ref-type="bibr" rid="article-20794.r6">[6]</xref><xref ref-type="bibr" rid="article-20794.r7">[7]</xref> Without proteins like dyskerin, the telomeres progressively shorten which causes the cells involved to undergo apoptosis or senescence. The instability of telomeres may also induce carcinogenesis, especially in rapidly dividing&#x000a0;cells. Numerous genes, including <italic toggle="yes">TINF2, TERC, TERT, C16orf57, NOLA2, NOLA3, WRAP53/TCAB1</italic>, and <italic toggle="yes">RTEL1</italic> are mutated in DKC.</p>
      </sec>
      <sec id="article-20794.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Males are affected more than females in a ratio of approximately 3:1, which corresponds with x-linked recessive being the most common inheritance pattern.<xref ref-type="bibr" rid="article-20794.r8">[8]</xref><xref ref-type="bibr" rid="article-20794.r9">[9]</xref> Female carriers have been reported to have milder phenotypes, although more severe phenotypes have also been reported in carriers.</p>
      </sec>
      <sec id="article-20794.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The clinical phenotype produced by telomere shortening with subsequent senescence, apoptosis, or carcinogenesis in dyskeratosis congenita varies greatly. Classically&#x000a0;the triad of oral leukoplakia, nail dystrophy, and reticular hyperpigmentation is seen.<xref ref-type="bibr" rid="article-20794.r10">[10]</xref> Nail dystrophy usually consists of thin dystrophic nails with longitudinal ridging, and may eventually develop dorsal pterygium.<xref ref-type="bibr" rid="article-20794.r11">[11]</xref> Reticular hyperpigmentation is usually in a fine, lace-like pattern and frequently occurs on the face,&#x000a0;upper trunk, and upper arms. Areas of hyperpigmentation&#x000a0;may be surrounded by hypopigmented areas, as well as telangiectasias and atrophic patches of skin. Oral leukoplakia is a premalignant condition commonly seen on the tongue (but may occur on other parts of mucosa) in those with DKC.<xref ref-type="bibr" rid="article-20794.r9">[9]</xref> Up to 90% may also be affected by&#x000a0;bone marrow failure.</p>
      </sec>
      <sec id="article-20794.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Histologic findings of dyskeratosis congenita are generally non-specific. Commonly, there are telangiectasias seen superficially, along with hyperkeratosis and atrophy of the epidermis.<xref ref-type="bibr" rid="article-20794.r12">[12]</xref> It is not uncommon to see many melanophages in the superficial dermis. Infrequently there is a vacuolar change in the basal layer of the epidermis, along with a mild interface lymphocytic infiltrate. Fibrotic changes may also be seen in the superficial dermis.</p>
      </sec>
      <sec id="article-20794.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Generally, patients with dyskeratosis congenita first develop presenting signs of dystrophic nails between the ages of 5 to 13 years.<xref ref-type="bibr" rid="article-20794.r2">[2]</xref>&#x000a0;Nail dystrophy usually consists&#x000a0;of longitudinal ridging, and may eventually develop dorsal pterygium. During late childhood, skin changes&#x000a0;start to develop. Reticular hyperpigmentation is usually in a fine lace-like pattern and frequently occurs on the face,&#x000a0;upper trunk, and upper arms. However,&#x000a0;other areas such as the thighs may also develop pigmentation changes. Areas of hyperpigmentation&#x000a0;may be surrounded by hypopigmented areas, as well as telangiectasias and atrophic patches of skin.<xref ref-type="bibr" rid="article-20794.r13">[13]</xref> Hyperhidrosis, acrocyanosis, keratoderma, the atrophic wrinkled skin of bony prominences as well as face and genitals, as well as thin graying hair may also be seen. Premalignant leukoplakia, along with blisters, erosions, and tooth decay may&#x000a0;affect the mouth. The development&#x000a0;of the musculoskeletal and neurological systems may be affected by short stature and developmental delay, respectively.<xref ref-type="bibr" rid="article-20794.r14">[14]</xref> Osteoporosis and avascular necrosis have also been described. Eyes may develop ectropion or entropion with subsequent corneal abrasions. Gastrointestinal and genitourinary systems sometimes are affected by stenosis, malignancy, or hepatic fibrosis.<xref ref-type="bibr" rid="article-20794.r9">[9]</xref> Lungs can also develop fibrosis. Bone marrow failure, myelodysplastic syndrome, or leukemia can cause changes in blood counts.<xref ref-type="bibr" rid="article-20794.r15">[15]</xref></p>
      </sec>
      <sec id="article-20794.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Evaluation and diagnosis is mainly a combination&#x000a0;of history and physical examination, biopsies of skin, mucosa, or bone marrow, and flow-fluorescence in situ hybridization (FISH). Biopsies of skin and mucosa show histological characteristics listed above along with possible malignancy-associated changes. Bone marrow biopsy shows associated bone marrow failure, myelodysplastic, or leukemia changes.<xref ref-type="bibr" rid="article-20794.r16">[16]</xref> FISH shows telomere shortening in leukocytes. Genetic analysis may reveal one of the&#x000a0;correlated genetic defects listed above.</p>
      </sec>
      <sec id="article-20794.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Treatment often involves an interprofessional approach. Surveillance&#x000a0;for associated complications is paramount. Lifelong annual skin screening, as well as sun protection, is warranted to detect and protect from cutaneous squamous cell carcinoma. Dental examinations twice per year are recommended by a dental professional to screen for oral malignancies. Yearly examinations by an otolaryngologist may be warranted to screen for squamous cell carcinoma. Gastroenterologists' involvement with screening endoscopies of the esophagus and/or colon for strictures or malignancies may be beneficial. Bone marrow examination should be performed at the time of diagnosis, and then accordingly pending biannual blood counts to screen for bone marrow failure or malignancy changes. Pulmonary function&#x000a0;tests should be done yearly to screen for signs of fibrosis. Calcium and vitamin D levels should be regularly checked and treated accordingly to&#x000a0;prevent osteoporosis and/or fractures. Eyes&#x000a0;may develop complications like a corneal abrasion secondary to associated eye problems like ectropion. Thus, regular eye examinations may be beneficial. Ultrasound of the liver should be done regularly, along with annual liver function tests.</p>
        <p>Transfusions may help intermittently alleviate bone marrow failure.&#x000a0; Medical treatment of bone marrow failure with stem cell transplantation is done when severe, but stem cell transplantation still has a poor long-term survival rate.<xref ref-type="bibr" rid="article-20794.r17">[17]</xref> Androgens, as well as granulocyte colony-stimulating factors (G-CSF), are sometimes used before stem cell transplantation. However, androgens are associated with tumors of the liver, and added G-CSF increases the risk of splenic rupture.<xref ref-type="bibr" rid="article-20794.r18">[18]</xref></p>
        <p>Patients should be encouraged to not participate in any carcinogenic habits or practices such as smoking, alcohol, or unprotected sun exposure. Surgical interventions&#x000a0;should be acted upon accordingly.</p>
      </sec>
      <sec id="article-20794.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Rothmund-Thomson syndrome and epidermolysis bullosa simplex with mottled pigmentation have similar poikiloderma. Dermatopathia pigmentosa&#x000a0;reticularis,&#x000a0;as well as Naegeli-Franceschetti-Jadassohn syndrome, may have similar reticulate hyperpigmentation. Fanconi anemia has a similar presentation to DKC but is due to chromosomal rearrangement and breakage. Patients with graft-versus-host disease have poikiloderma, and mucosal changes are lichen planus-like.</p>
        <p>There are also a few variants of DKC that have findings of DKC with a few other specific characteristics. Hoyeraal-Hreidarsson syndrome&#x000a0;is like DKC but also has cerebellar hypoplasia and intrauterine growth restriction.<xref ref-type="bibr" rid="article-20794.r19">[19]</xref>&#x000a0;Cerebellar hypoplasia and exudative retinopathy distinguish Revesz syndrome.</p>
      </sec>
      <sec id="article-20794.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Patients with dyskeratosis congenita have a shortened lifespan. Causes of death from most to least common are bone marrow failure, lung disease, and malignancies.</p>
      </sec>
      <sec id="article-20794.s12" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Dyskeratosis congenita is best managed by an interprofessional team that includes oncology nurses. Because of the high risk of malignancy, patients must not only be screened regularly but should be educated on the harms of nicotine, alcohol, and too much sunlight.</p>
      </sec>
      <sec id="article-20794.s13">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=20794&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=20794">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/genetic-disorders/dyskeratosis-congenita/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=20794">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/20794/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=20794">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-20794.s14">
        <title>References</title>
        <ref id="article-20794.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>MILGROM</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>STOLL</surname>
                <given-names>HL</given-names>
              </name>
              <name>
                <surname>CRISSEY</surname>
                <given-names>JT</given-names>
              </name>
            </person-group>
            <article-title>DYSKERATOSIS CONGENITA. A CASE WITH NEW FEATURES.</article-title>
            <source>Arch Dermatol</source>
            <year>1964</year>
            <month>Mar</month>
            <volume>89</volume>
            <fpage>345</fpage>
            <page-range>345-9</page-range>
            <pub-id pub-id-type="pmid">14096348</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20794.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Savage</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Alter</surname>
                <given-names>BP</given-names>
              </name>
            </person-group>
            <article-title>Dyskeratosis congenita.</article-title>
            <source>Hematol Oncol Clin North Am</source>
            <year>2009</year>
            <month>Apr</month>
            <volume>23</volume>
            <issue>2</issue>
            <fpage>215</fpage>
            <page-range>215-31</page-range>
            <pub-id pub-id-type="pmid">19327580</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20794.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kirwan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Dokal</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Dyskeratosis congenita, stem cells and telomeres.</article-title>
            <source>Biochim Biophys Acta</source>
            <year>2009</year>
            <month>Apr</month>
            <volume>1792</volume>
            <issue>4</issue>
            <fpage>371</fpage>
            <page-range>371-9</page-range>
            <pub-id pub-id-type="pmid">19419704</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20794.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Calado</surname>
                <given-names>RT</given-names>
              </name>
              <name>
                <surname>Young</surname>
                <given-names>NS</given-names>
              </name>
            </person-group>
            <article-title>Telomere diseases.</article-title>
            <source>N Engl J Med</source>
            <year>2009</year>
            <month>Dec</month>
            <day>10</day>
            <volume>361</volume>
            <issue>24</issue>
            <fpage>2353</fpage>
            <page-range>2353-65</page-range>
            <pub-id pub-id-type="pmid">20007561</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20794.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ballew</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Savage</surname>
                <given-names>SA</given-names>
              </name>
            </person-group>
            <article-title>Updates on the biology and management of dyskeratosis congenita and related telomere biology disorders.</article-title>
            <source>Expert Rev Hematol</source>
            <year>2013</year>
            <month>Jun</month>
            <volume>6</volume>
            <issue>3</issue>
            <fpage>327</fpage>
            <page-range>327-37</page-range>
            <pub-id pub-id-type="pmid">23782086</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20794.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Deng</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Glousker</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Molczan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Fox</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Lamm</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Dheekollu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Weizman</surname>
                <given-names>OE</given-names>
              </name>
              <name>
                <surname>Schertzer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Vladimirova</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Schug</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Aker</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Londo&#x000f1;o-Vallejo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kaestner</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Lieberman</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Tzfati</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Inherited mutations in the helicase RTEL1 cause telomere dysfunction and Hoyeraal-Hreidarsson syndrome.</article-title>
            <source>Proc Natl Acad Sci U S A</source>
            <year>2013</year>
            <month>Sep</month>
            <day>03</day>
            <volume>110</volume>
            <issue>36</issue>
            <fpage>E3408</fpage>
            <page-range>E3408-16</page-range>
            <pub-id pub-id-type="pmid">23959892</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20794.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Knight</surname>
                <given-names>SW</given-names>
              </name>
              <name>
                <surname>Heiss</surname>
                <given-names>NS</given-names>
              </name>
              <name>
                <surname>Vulliamy</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Greschner</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Stavrides</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Pai</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Lestringant</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Varma</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Mason</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Dokal</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Poustka</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>X-linked dyskeratosis congenita is predominantly caused by missense mutations in the DKC1 gene.</article-title>
            <source>Am J Hum Genet</source>
            <year>1999</year>
            <month>Jul</month>
            <volume>65</volume>
            <issue>1</issue>
            <fpage>50</fpage>
            <page-range>50-8</page-range>
            <pub-id pub-id-type="pmid">10364516</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20794.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kirwan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Dokal</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Dyskeratosis congenita: a genetic disorder of many faces.</article-title>
            <source>Clin Genet</source>
            <year>2008</year>
            <month>Feb</month>
            <volume>73</volume>
            <issue>2</issue>
            <fpage>103</fpage>
            <page-range>103-12</page-range>
            <pub-id pub-id-type="pmid">18005359</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20794.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alter</surname>
                <given-names>BP</given-names>
              </name>
              <name>
                <surname>Giri</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Savage</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Rosenberg</surname>
                <given-names>PS</given-names>
              </name>
            </person-group>
            <article-title>Cancer in dyskeratosis congenita.</article-title>
            <source>Blood</source>
            <year>2009</year>
            <month>Jun</month>
            <day>25</day>
            <volume>113</volume>
            <issue>26</issue>
            <fpage>6549</fpage>
            <page-range>6549-57</page-range>
            <pub-id pub-id-type="pmid">19282459</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20794.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bongiorno</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rivard</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hammer</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kentosh</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Malignant transformation of oral leukoplakia in a patient with dyskeratosis congenita.</article-title>
            <source>Oral Surg Oral Med Oral Pathol Oral Radiol</source>
            <year>2017</year>
            <month>Oct</month>
            <volume>124</volume>
            <issue>4</issue>
            <fpage>e239</fpage>
            <page-range>e239-e242</page-range>
            <pub-id pub-id-type="pmid">28923296</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20794.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Monoi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sugawa</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kato</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Seki</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Yoshida</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Shiraishi</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Sakaguchi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Ogawa</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Takita</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Atypical dyskeratosis congenita diagnosed using whole-exome sequencing.</article-title>
            <source>Pediatr Int</source>
            <year>2017</year>
            <month>Aug</month>
            <volume>59</volume>
            <issue>8</issue>
            <fpage>933</fpage>
            <page-range>933-935</page-range>
            <pub-id pub-id-type="pmid">28643950</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20794.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>G&#x000fc;ng&#x000f6;r</surname>
                <given-names>&#x0015e;</given-names>
              </name>
              <name>
                <surname>Erdemir</surname>
                <given-names>AV</given-names>
              </name>
              <name>
                <surname>G&#x000f6;nc&#x000fc;</surname>
                <given-names>EK</given-names>
              </name>
              <name>
                <surname>G&#x000fc;rel</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>&#x000d6;zekinci</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>A case of dyskeratosis congenita with dermoscopic and reflectance confocal microscopic features.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2015</year>
            <month>Jul</month>
            <volume>73</volume>
            <issue>1</issue>
            <fpage>e11</fpage>
            <page-range>e11-3</page-range>
            <pub-id pub-id-type="pmid">26089061</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20794.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kutbay</surname>
                <given-names>NO</given-names>
              </name>
              <name>
                <surname>Yurekli</surname>
                <given-names>BS</given-names>
              </name>
              <name>
                <surname>Erdemir</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Karaca</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Unal</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Yaman</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Ozkinay</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Saygili</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>A case of dyskeratosis congenita associated with hypothyroidism and hypogonadism.</article-title>
            <source>Hormones (Athens)</source>
            <year>2016</year>
            <month>Apr</month>
            <volume>15</volume>
            <issue>2</issue>
            <fpage>297</fpage>
            <page-range>297-299</page-range>
            <pub-id pub-id-type="pmid">27376432</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20794.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Powell</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Dokal</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Carr</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Taibjee</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cave</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Moss</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>X-linked dyskeratosis congenita presenting in adulthood with photodamaged skin and epiphora.</article-title>
            <source>Clin Exp Dermatol</source>
            <year>2014</year>
            <month>Apr</month>
            <volume>39</volume>
            <issue>3</issue>
            <fpage>310</fpage>
            <page-range>310-4</page-range>
            <pub-id pub-id-type="pmid">24635067</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20794.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Revesz</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Fletcher</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>al-Gazali</surname>
                <given-names>LI</given-names>
              </name>
              <name>
                <surname>DeBuse</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Bilateral retinopathy, aplastic anaemia, and central nervous system abnormalities: a new syndrome?</article-title>
            <source>J Med Genet</source>
            <year>1992</year>
            <month>Sep</month>
            <volume>29</volume>
            <issue>9</issue>
            <fpage>673</fpage>
            <page-range>673-5</page-range>
            <pub-id pub-id-type="pmid">1404302</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20794.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Piard</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Holder-Espinasse</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Aral</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Gigot</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Rio</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tardieu</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Puzenat</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Goldenberg</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Toutain</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Franques</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>MacDermot</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Bessis</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Boute</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Callier</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Gueneau</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Huet</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Vabres</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Catteau</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Faivre</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Thauvin-Robinet</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Systematic search for neutropenia should be part of the first screening in patients with poikiloderma.</article-title>
            <source>Eur J Med Genet</source>
            <year>2012</year>
            <month>Jan</month>
            <volume>55</volume>
            <issue>1</issue>
            <fpage>8</fpage>
            <page-range>8-11</page-range>
            <pub-id pub-id-type="pmid">21872685</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20794.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gadalla</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Sales-Bonfim</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Carreras</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Alter</surname>
                <given-names>BP</given-names>
              </name>
              <name>
                <surname>Antin</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Ayas</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bodhi</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Davis</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Davies</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Deconinck</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Deeg</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Duerst</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Fasth</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ghavamzadeh</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Giri</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Goldman</surname>
                <given-names>FD</given-names>
              </name>
              <name>
                <surname>Kolb</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Krance</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kurtzberg</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Leung</surname>
                <given-names>WH</given-names>
              </name>
              <name>
                <surname>Srivastava</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Or</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Richman</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Rosenberg</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>Toledo Codina</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Shenoy</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Soci&#x000e9;</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Tolar</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Eapen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Savage</surname>
                <given-names>SA</given-names>
              </name>
            </person-group>
            <article-title>Outcomes of allogeneic hematopoietic cell transplantation in patients with dyskeratosis congenita.</article-title>
            <source>Biol Blood Marrow Transplant</source>
            <year>2013</year>
            <month>Aug</month>
            <volume>19</volume>
            <issue>8</issue>
            <fpage>1238</fpage>
            <page-range>1238-43</page-range>
            <pub-id pub-id-type="pmid">23751955</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20794.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Islam</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rafiq</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kirwan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Walne</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cavenagh</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Vulliamy</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Dokal</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Haematological recovery in dyskeratosis congenita patients treated with danazol.</article-title>
            <source>Br J Haematol</source>
            <year>2013</year>
            <month>Sep</month>
            <volume>162</volume>
            <issue>6</issue>
            <fpage>854</fpage>
            <page-range>854-6</page-range>
            <pub-id pub-id-type="pmid">23782100</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20794.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aalfs</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>van den Berg</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Barth</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>Hennekam</surname>
                <given-names>RC</given-names>
              </name>
            </person-group>
            <article-title>The Hoyeraal-Hreidarsson syndrome: the fourth case of a separate entity with prenatal growth retardation, progressive pancytopenia and cerebellar hypoplasia.</article-title>
            <source>Eur J Pediatr</source>
            <year>1995</year>
            <month>Apr</month>
            <volume>154</volume>
            <issue>4</issue>
            <fpage>304</fpage>
            <page-range>304-8</page-range>
            <pub-id pub-id-type="pmid">7607282</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
